Elia Stupka
Managing Director at Angelini Ventures
Singapore
Overview
Work Experience
Managing Director
2021 - Current
Managing Director at Angelini Ventures, a global healthcare venture fund created by the Angelini Industries group to create, invest and shape the healthcare companies of the future
Strategic Advisor
2020
SVP and General Manager - Life Sciences Business
2019 - 2020
General Manager of the Life Sciences Business Unit, providing solutions at the intersection of the providers and the life science industry, accelerating clinical development and success of new therapies by working with our extensive provider network and the enriched real world data of 100M+ patients within the network to drive improved clinical and financial outcomes.
Chief Analytics Officer, SVP - Life Sciences Business
2018 - 2019
Providing technology leadership in the area of analytics. Building out a new function located in Cambridge, MA to leverage Health Catalyst aggregated data to accelerate the discovery and development of new therapies.
Health Care DataWorks offers business intelligence solutions and empowers healthcare organizations to optimize their operations.
Raised $4,999,541.00 from Cedars Sinai and MemorialCare Innovation Fund.
Innovation Councilor
2020
Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors.
Raised $23,975,000.00 from Bill & Melinda Gates Foundation.
Strategic Advisor
2020
Leapcure offers tools for clinical trial patient recruitment, engagement, and retention.
Raised $125,000.00 from 500 Global and 500 Global.
Venture Partner
2019
Strategic Advisor
2019
Duality empowers organizations to extract business value from sensitive data by enabling secure data collaborations within their ecosystem.
Raised $50,000,000.00 from Intel Capital, Euclidean Capital, NAventures, Hearst Ventures, Team8 and LG Technology Ventures.
Strategic Advisor
2018
Strategic Advisor
2018
Strategic Advisor
2018
Reboot Rx is a nonprofit health tech startup dedicated to fast-tracking the development of affordable cancer treatments.
Raised $1,000,000.00 from Amazon Web Services, The Draper Richards Kaplan Foundation, Lyda Hill and Arnold Ventures.
Scientific Advisory Board Member
2016
Alkahest develops therapies derived from blood to treat neurological diseases, with an emphasis on age-related cognitive decline.
Raised $41,000,000.00 from Michael J. Fox Foundation.
Education
Leading Innovative Enterprises Program
2008 - 2008
M.Res.
1998 - 1999
Bachelor of Science (B.Sc.)
1995 - 1998
International Baccalaureate
1993 - 1995
Maturita
1990 - 1993